Ligand ID: ASR


Drugbank ID:
DB03006
(Arsanilic acid)


Indication:
An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals. [PubChem]

Get human targets for ASR in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'ASR' AND SARS-RELATED PROTEINS ONLY

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		1ssk NUCLEOCAPSID PROTEIN
(SARSr-CoV)		4 / 6
ASP A  60
GLY A  57
THR A  93
PRO A  95
1.42A21.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		1ssk NUCLEOCAPSID PROTEIN
(SARSr)		4 / 6
ASP A  60
GLY A  92
THR A 119
PRO A 120
1.45A21.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		1wnc E2 GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN C1154
ALA B 940
ASN B 937
0.91A22.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		1wyy E2 GLYCOPROTEIN
(SARSr-CoV)		4 / 6
ASN B1168
GLY A 928
THR B 925
SER B 924
1.62A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		1x7q BETA-2-MICROGLOBULIN
(Homo
sapiens)		4 / 6
GLY B  18
THR B  71
PRO B  72
SER B  20
1.71A16.67
None
None
None
GOL  B5007 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		1yo4 HYPOTHETICAL PROTEIN
X4
(SARSr-CoV)		4 / 6
ASP A  54
GLY A  55
THR A  56
PRO A  -1
1.64A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		3 / 3
ASN B1142
ALA B1145
ASN B1028
1.21A20.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN K  37
ALA J   7
ASN K  42
1.18A21.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN D   6
ALA C  40
ASN C  37
1.09A18.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		3 / 3
ASN B 269
ALA B 271
ASN B 213
1.23A19.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN B 937
ALA D1156
ASN B 942
1.24A15.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		2bez SPIKE GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN F1155
ALA C 940
ASN C 937
1.03A20.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		2dd8 IGG HEAVY CHAIN
(Homo
sapiens)		4 / 6
GLY H 133
THR H 135
PRO H 185
SER H 136
1.25A17.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		3 / 3
ASN A  88
ALA A  90
ASN A  32
1.24A19.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		3 / 3
ASN A  89
ALA A 150
ASN A 147
1.09A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		2g9t ORF1A POLYPROTEIN
(SARSr-CoV)		4 / 6
ASN B  62
GLY B  50
PRO B  59
SER B  67
1.68A17.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		2k87 NSP3 OF REPLICASE
POLYPROTEIN 1A
(SARSr)		4 / 6
ASN A  17
THR A 111
PRO A 113
SER A  19
1.50A24.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		3 / 3
ASN B   4
ALA B  22
ASN B  11
1.33A16.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		2xyv PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		4 / 6
GLY A  73
THR A  82
PRO A  80
SER A 105
1.67A18.75
SAH  A1300 (-4.1A)
None
SAH  A1300 (-3.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		3e9s NSP3
(SARSr-CoV)		3 / 3
ASN A  89
ALA A 150
ASN A 147
1.09A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		3fzd 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 6
ASN A 119
GLY A 120
PRO A 122
SER A 123
1.28A20.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		3i6k HLA, A-2
(Homo
sapiens)		4 / 6
ASP A 238
GLY A 237
THR A 240
SER A 207
1.49A16.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		3i6k BETA-2-MICROGLOBULIN
(Homo
sapiens)		4 / 6
GLY F  18
THR F  71
PRO F  72
SER F  20
1.58A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		3vb3 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 6
ASN B 119
GLY B 120
PRO B 122
SER B 123
1.64A20.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		4 / 6
ASP A 287
GLY A 288
THR A 275
SER A 112
1.78A18.15
NHE  A 403 (-2.9A)
NHE  A 403 (-3.3A)
None
NA  A 402 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		3 / 3
ASN A  89
ALA A 150
ASN A 147
1.06A18.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		4ow0 PAPAIN-LIKE PROTEASE
(SARS-COV
Urbani)		3 / 3
ASN A  89
ALA A 150
ASN A 147
0.94A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		4ow0 PAPAIN-LIKE PROTEASE
(SARS-COV
Urbani)		4 / 6
ASN A 216
GLY A 220
THR A 232
SER A 222
1.76A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		4rna PAPAIN-LIKE PROTEASE
(Human
betacoronavirus
2c
EMC/2012)		4 / 6
GLY A 248
THR A 308
PRO A 250
SER A 167
1.69A17.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)		3 / 3
ASN B 142
ALA B 145
ASN B  28
1.28A20.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		5c8u GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		4 / 6
GLY B   6
THR B   5
PRO A   8
SER A  11
1.77A14.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		3 / 3
ASN A  89
ALA A 150
ASN A 147
1.16A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		3 / 3
ASN B  89
ALA B 150
ASN B 147
0.98A19.30
None
None
SO4  B 402 (-3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		4 / 6
ASP C 600
GLY C 579
THR A 841
SER A 717
1.51A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		5x5c S PROTEIN
(MERS-CoV)		4 / 6
GLY A 732
THR A 741
PRO A 742
SER A 743
1.39A6.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 6
ASN C 227
GLY C 104
THR C 106
SER C 111
1.36A8.57
ASN  C 227 ( 0.6A)
GLY  C 104 ( 0.0A)
THR  C 106 ( 0.8A)
SER  C 111 ( 0.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		5zvm PAN-COV INHIBITORY
PEPTIDE EK1
SPIKE GLYCOPROTEIN
(SARSr-CoV;
synthetic
construct)		3 / 3
ASN a  12
ALA B 940
ASN B 937
0.99A13.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 6
ASN A 304
GLY A 579
THR C 841
SER C 717
1.67A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6ack ACE2
(Homo
sapiens)		3 / 3
ASN D 601
ALA D 246
ASN D 250
0.68A11.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6ack ACE2
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARSr-CoV)		4 / 6
ASN D 330
ASP D 355
GLY D 326
THR C 487
1.42A11.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN B 505
ALA B 508
ASN B 530
1.28A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 6
ASP B 600
GLY B 579
THR C 841
SER C 717
1.39A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		3 / 3
ASN A 896
ALA A 885
ASN A 889
1.06A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6iex MHC CLASS I ANTIGEN
(Homo
sapiens)		3 / 3
ASN A 114
ALA A 125
ASN A 127
1.34A16.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6m1d ACE2
(Homo
sapiens)		3 / 3
ASN D 149
ALA D 153
ASN D 277
0.62A9.49
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 6
ASN C 960
GLY A 534
THR A 533
SER C 964
1.69A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6nb7 SPIKE GLYCOPROTEIN
(SARSr-CoV)		3 / 3
ASN B 896
ALA C1069
ASN C1107
1.11A8.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6nur NSP12
(SARSr-CoV)		4 / 6
ASN A 781
GLY A 774
THR A 710
SER A 709
1.65A9.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6vw1 ACE2
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)		4 / 6
ASP B 355
GLY F 502
THR F 500
PRO F 499
1.53A11.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6vw1 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 6
ASN F 487
GLY F 476
THR F 478
PRO F 479
1.46A21.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 6
GLY H 134
THR H 135
PRO H 185
SER H 186
1.60A18.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		3 / 3
ASN L 210
ALA L 193
ASN L 152
1.51A21.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 6
GLY H 133
THR H 135
PRO H 185
SER H 186
1.64A18.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 6
ASN L  37
GLY L  74
THR L  75
SER L  25
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 6
GLY B 138
THR B 139
PRO B 189
SER B 190
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 6
ASP L  76
GLY L  74
THR L  75
SER L  25
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6yla LIGHT CHAIN
(Homo
sapiens)		3 / 3
ASN C 216
ALA C 199
ASN C 158
1.66A
MLI  C 306 ( 3.7A)
MLI  C 304 ( 3.9A)
MLI  C 304 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA140_0
(LYSOZYME C)		6ym0 LIGHT CHAIN
(Homo
sapiens)		3 / 3
ASN L 216
ALA L 199
ASN L 158
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6ym0 LIGHT CHAIN
(Homo
sapiens)		4 / 6
ASP L  76
GLY L  74
THR L  75
SER L  25
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6ym0 LIGHT CHAIN
(Homo
sapiens)		4 / 6
ASN L  37
GLY L  74
THR L  75
SER L  25
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 6
ASP L  76
GLY L  74
THR L  75
SER L  25
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 6
ASP C  76
GLY C  74
THR C  75
SER C  25
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 6
ASN C  37
GLY C  74
THR C  75
SER C  25
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N4F_A_ASRA141_0
(LYSOZYME C)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 6
ASN L  37
GLY L  74
THR L  75
SER L  25
1.77A
None